Correlation Between Dupont De and Klaria Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dupont De and Klaria Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Klaria Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Klaria Pharma Holding, you can compare the effects of market volatilities on Dupont De and Klaria Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Klaria Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Klaria Pharma.

Diversification Opportunities for Dupont De and Klaria Pharma

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Dupont and Klaria is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Klaria Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Klaria Pharma Holding and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Klaria Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Klaria Pharma Holding has no effect on the direction of Dupont De i.e., Dupont De and Klaria Pharma go up and down completely randomly.

Pair Corralation between Dupont De and Klaria Pharma

Allowing for the 90-day total investment horizon Dupont De is expected to generate 7.89 times less return on investment than Klaria Pharma. But when comparing it to its historical volatility, Dupont De Nemours is 6.03 times less risky than Klaria Pharma. It trades about 0.01 of its potential returns per unit of risk. Klaria Pharma Holding is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  64.00  in Klaria Pharma Holding on August 29, 2024 and sell it today you would lose (4.00) from holding Klaria Pharma Holding or give up 6.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Dupont De Nemours  vs.  Klaria Pharma Holding

 Performance 
       Timeline  
Dupont De Nemours 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Dupont De Nemours are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Dupont De is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Klaria Pharma Holding 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Klaria Pharma Holding are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Klaria Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Dupont De and Klaria Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dupont De and Klaria Pharma

The main advantage of trading using opposite Dupont De and Klaria Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Klaria Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klaria Pharma will offset losses from the drop in Klaria Pharma's long position.
The idea behind Dupont De Nemours and Klaria Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years